Ben Hendrix

Mar 27, 2026

Ben Hendrix rated SNDA as Outperform on Mar 27, 2026, setting a price target of 39. Shares have remained stable near 32.18, leaving the 39 target still in play.

Mar 10, 2026

On Mar 10, 2026, Ben Hendrix published a Outperform outlook on ARDT, with a target of 14. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 8.66.

Mar 04, 2026

Ben Hendrix on Mar 04, 2026 assigned SGRY a Outperform rating, with a price target of 31. The recommendation remains pending validation as shares consolidate around 12.18.

Mar 02, 2026

PNTG was rated Outperform by Ben Hendrix on Mar 02, 2026, with a price objective of 41. This case shows how bullish projections can fail, with the stock now below 29.66.

Feb 27, 2026

Ben Hendrix issued a Outperform recommendation for PACS on Feb 27, 2026, price target set at 52. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Feb 26, 2026

On Feb 26, 2026, ACHC was evaluated by Ben Hendrix, who gave a Outperform rating and target of 28. This case illustrates how a timely bullish rating can translate into tangible gains of 7.49%.

Feb 24, 2026

Ben Hendrix rated MAX as Outperform on Feb 24, 2026, setting a price target of 18. Shares have remained stable near 9.36, leaving the 18 target still in play.

Feb 12, 2026

THC received a Outperform rating from Ben Hendrix on Feb 12, 2026, aiming for 277. The rating hasn’t played out as hoped, with the stock trading 18.98% below expectations.

Feb 09, 2026

Ben Hendrix on Feb 09, 2026 assigned ENSG a Outperform rating, with a price target of 222. The recommendation remains pending validation as shares consolidate around 196.62.

Feb 06, 2026

On Feb 06, 2026, Ben Hendrix reaffirmed CI with a Outperform rating, targeting 333. Shares slid 7.54% despite the recommendation, highlighting downside risks.

Feb 02, 2026

CON was rated Outperform by Ben Hendrix on Feb 02, 2026, with a price objective of 31. This case shows how bullish projections can fail, with the stock now below 20.89.

Jan 29, 2026

On Jan 29, 2026, Ben Hendrix initiated coverage on BKD with a Outperform rating and target of 17. Neutral price movement of -3.79% leaves room for interpretation.

Jan 28, 2026

Ben Hendrix issued a Outperform recommendation for UNH on Jan 28, 2026, price target set at 361. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Jan 28, 2026

On Jan 28, 2026, HCA was evaluated by Ben Hendrix, who gave a Outperform rating and target of 555. So far, the Buy call awaits clearer momentum, with shares flat at 471.84.

Nov 07, 2025

On Nov 07, 2025, ADUS was given a Outperform rating by Ben Hendrix, with a target price of 139. Despite the Buy call, shares fell from 91.59 to 91.59, challenging the optimistic stance.

Oct 30, 2025

CVS received a Outperform rating from Ben Hendrix on Oct 30, 2025, aiming for 93. Price action was muted, as shares hovered around 73.49 despite the bullish outlook.

Jul 25, 2025

Ben Hendrix on Jul 25, 2025 assigned CYH a Outperform rating, with a price target of 5. The Buy call aligned well with market performance, producing a gain of 6.86%.

Feb 26, 2025

On Feb 26, 2025, Ben Hendrix reaffirmed AHCO with a Outperform rating, targeting 14. The recommendation was supported by strong follow-through as the stock rose from 12.03 to 12.03.

Feb 11, 2025

EHC was rated Outperform by Ben Hendrix on Feb 11, 2025, with a price objective of 110. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

Jul 18, 2024

On Jul 18, 2024, ELV was evaluated by Ben Hendrix, who gave a Outperform rating and target of 585. Investors saw limited payoff as shares fell short of the 585 target.